CFDE Data Portal | Search GUSBP15

	Label	Description
	GUSBP15 Gene (Entity type)	ENSG00000300109 - GUSB pseudogene 15
	GSE146358 dopamine 5 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE81796 enzalutamide LNCaP C4-2 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE173116 GSE173118 ML-7 3 v 10 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE182680 GSE182683 dexamethasone 5 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE182680 GSE182683 dexamethasone 5 v 12 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE131660 piperlongumine 2 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE111247 temozolomide LN-308 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE182680 GSE182683 dexamethasone 0 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE172409 dopamine neuron 1 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS

GUSBP15

ENSG00000300109 - GUSB pseudogene 15

GSE146358 dopamine 5 v 2 human up

A Gene Set from LINCS

GSE81796 enzalutamide LNCaP C4-2 0 v 1 human up

A Gene Set from LINCS

GSE173116 GSE173118 ML-7 3 v 10 human up

A Gene Set from LINCS

GSE182680 GSE182683 dexamethasone 5 v 4 human up

A Gene Set from LINCS

GSE182680 GSE182683 dexamethasone 5 v 12 human up

A Gene Set from LINCS

GSE131660 piperlongumine 2 v 0 human dn

A Gene Set from LINCS

GSE111247 temozolomide LN-308 0 v 1 human up

A Gene Set from LINCS

GSE182680 GSE182683 dexamethasone 0 v 4 human up

A Gene Set from LINCS

GSE172409 dopamine neuron 1 v 4 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.